Improving compliance and standard of data collection and use in trials: setting standards for the next generation

Principal investigator(s)
Madeline Pe
EORTC
Brussels, Belgium

Project summary

The primary objective of this study is to investigate ways on how to improve the completion rates for health-related quality of life (HRQOL) assessments in EORTC cancer trials. The output of this project will be in the form of guidelines and a training program that can be used by the EORTC QLG and EORTC DOGs for the design and collection of HRQOL data in EORTC trials.

Achievements

  • literature reviews completed and being finalised.
  • Finalising summary of the completion rates of the EORTC trials.
  • Two abstracts for the literature reviews and completion rates summary accepted for ISOQOL 2023 as oral and poster presentations.

Currents status:

  • Preparing interview questions.
  • Finalizing completion rates summary and preparing manuscript for the literature reviews.
  • Preparing interview questions and guidelines for the stakeholders and QoL experts.

Future plans

We plan to complete conducting literature reviews and existing EORTC guidelines within the first 6 months after kick-off. We will provide summary of completion rates for closed EORTC trials at the next group meeting. We plan to conduct stakeholder interviews on how we can improve QoL compliance rates on clinical trials after completing reviews and summarizing completion rates of EORTC trials.

We will also conduct a 2-day meeting with liaisons and external experts. We will also start writing summary reports and drafting abstracts and publications.

In the 2nd year, we will complete compliance guidelines development, setting up educational program for liaisons and development of standardized slide deck. We will prepare a final report and recommendations.

For patients

The aim of this project is to find and develop strategies that will substantially contribute to the already existing efforts to improve the process of health-related quality of life (HRQoL) assessment in EORTC cancer clinical studies, and therefore improving the compliance rates for HRQOL assessments.

Go to Top